Phase III trial of gemcitabine plus docetaxel versus capecitabine plus docetaxel with planned crossover to the alternate single agent in metastatic breast cancer. (Q33392873)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase III trial of gemcitabine plus docetaxel versus capecitabine plus docetaxel with planned crossover to the alternate single agent in metastatic breast cancer. |
scientific article |
Statements
Phase III trial of gemcitabine plus docetaxel versus capecitabine plus docetaxel with planned crossover to the alternate single agent in metastatic breast cancer (English)
A D Seidman
A Brufsky
R H Ansari
L L Hart
R S Stein
L S Schwartzberg
J F Stewart
C A Russell
S-C Chen
L E Fein
S-B Kim
J Cavalheiro
L Zhao
J F Gill
C K Obasaju
M Orlando
17 November 2010